Novartis to Acquire Tourmaline Bio, Expanding ASCVD Pipeline
September 9, 2025 – Basel – In a move set to strengthen its cardiovascular disease portfolio, Novartis announced an...
Mergers & Acquisitions for New Therapy
AbbVie Acquires Gilgamesh Pharmaceuticals’ Bretisilocin, A Novel Psychedelic Therapy for Major Depressive Disorder
AbbVie (NYSE: ABBV) has announced a definitive agreement to acquire Gilgamesh Pharmaceuticals’ lead investigational candidate bretisilocin (GM-2505), a next-generation...
Terumo Acquires OrganOx: A New Era in Organ Preservation
Terumo Corporation is acquiring UK-based OrganOx Limited for approximately USD 1.5 billion, enhancing its entry into the organ transplantation...
EVERSANA and Waltz Health Merger: Redefining Pharma Commercialization
EVERSANA and Waltz Health announced a merger today to form a unified healthcare platform designed to redefine pharmaceutical commercialization...
Sanofi Strengthens Vaccine Pipeline with Acquisition of Vicebio
Paris, France — August 21, 2025 – Sanofi has announced the acquisition of Vicebio, a biotechnology company specializing in...
Private Equity Firm, THL to Acquire Clinical Trial Site Network, Headlands Research from KKR
Lake Worth, FL. & New York, August 23, 2025 – Thomas H. Lee Partners (THL) has entered into a...
AbbVie Completes $2.1B Acquisition of Capstan Therapeutics, Advancing In Vivo CAR-T Innovation
NORTH CHICAGO, IL. and SAN DIEGO, CA, August 19, 2025 – AbbVie (NYSE: ABBV) and Capstan Therapeutics, Inc. (“Capstan”),...